Effects of vesnarinone on nitric oxide synthesis in rat cardiac myocytes

Cardiovasc Res. 1998 Apr;38(1):192-7. doi: 10.1016/s0008-6363(97)00317-9.

Abstract

Objective: The purpose of this study was to investigate the effects of vesnarinone on nitric oxide (NO) synthesis in cardiac myocytes.

Methods: We measured the accumulation of nitrite, a stable oxidation product of NO synthase (iNOS) protein in cultured neonatal rat cardiac myocytes.

Results: Incubation of the cultures with interleukin-1 beta (IL-1 beta; 10 ng/ml) and tumor necrosis factor alpha (TNF alpha; 10 ng/ml) caused a marked increase in nitrite production. Although vesnarinone by itself showed no effect on nitrite accumulation, it enhanced cytokine-induced nitrite production by cardiac myocytes in a dose-dependent manner. The effect of vesnarinone was completely abolished in the presence of NG-monomethyl-L-arginine or actinomycin D. The vesnarinone-induced nitrite production was accompanied by increased iNOS protein expression. In the presence of dibutyryl-cAMP, cytokine-induced nitrite accumulation was further increased, but the stimulatory effect on vesnarinone on nitrite accumulation was diminished. The effect of vesnarinone was also inhibited by Rp-8-Br-cAMPS, a competitive inhibitor of protein kinase A, in a dose-dependent manner.

Conclusions: These findings indicate that vesnarinone increases NO synthesis in cytokine-stimulated cardiac myocytes, at least partially through a cAMP-dependent pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / analogs & derivatives
  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Bucladesine / pharmacology
  • Cardiotonic Agents / pharmacology*
  • Cells, Cultured
  • Culture Media, Conditioned / chemistry
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Dactinomycin / pharmacology
  • Dose-Response Relationship, Drug
  • Interleukin-1 / pharmacology
  • Myocardium / metabolism*
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase / analysis
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type II
  • Nitrites / analysis
  • Protein Synthesis Inhibitors / pharmacology
  • Pyrazines
  • Quinolines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Thionucleotides / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology
  • omega-N-Methylarginine / pharmacology

Substances

  • 8-bromoadenosine-3',5'-cyclic monophosphorothioate
  • Cardiotonic Agents
  • Culture Media, Conditioned
  • Interleukin-1
  • Nitrites
  • Protein Synthesis Inhibitors
  • Pyrazines
  • Quinolines
  • Thionucleotides
  • Tumor Necrosis Factor-alpha
  • Dactinomycin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • omega-N-Methylarginine
  • Nitric Oxide
  • vesnarinone
  • Bucladesine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases